Investing Profile

Krishna Yeshwant

VCInvestor
General Partner at GV
gv.com/team/krishna-yeshwant/Boston, Massachusetts
Photo of Krishna Yeshwant, General Partner at GV (Google Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
507 CONNECTIONS
Harvard Business School Network
418 CONNECTIONS
Google Network
304 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
cb
GV (Google Ventures) General Partner
$250K - $50.0M
$25.0M
44
$8B
CompanyStageDateRound SizeTotal Raised
Nimbus Therapeutics
Private EquitySep 2023$210M
$640M
Co-investors: Peter Kolchinsky (RA Capital), Bruce Booth (Atlas Venture), Laura Stoppel (RA Capital), Vicki Sato (ARCH Venture Partners), Nikola Trbovic (Pfizer Venture Investments), Rajeev Dadoo (SR One), Bill Gates
Thatch
SeedFeb 2023$6M
$9M
Co-investors: Jenny Lefcourt (Freestyle Capital), Julie Yoo (Andreessen Horowitz), Riley Newman (Wave Capital), Sara Adler (Wave Capital)
Fractyl Health
Series FAug 2022
Series DNov 2017$44M
$44M
Xilis
Series AJul 2022$19M
Series AJul 2021$70M
$92M
Co-investors: Wesley Chan (FPV Fund), Ayman AlAbdallah
Mirvie
Series BMay 2022$45M
$45M
LifeMine Therapeutics
Series CMar 2022$180M
Series ASep 2017$70M
$250M
Co-investors: Robert Nelsen (ARCH Venture Partners), Jim Tananbaum (Foresite Capital)
DNAnexus
Series HMar 2022$200M
Series GJun 2020$100M
Series FFeb 2019$68M
Series EJan 2018$58M
Series CJan 2014$15M
Series BOct 2011$15M
$460M
Co-investors: Jeff Clavier (Uncork Capital), Manu Kumar (K9 Ventures), Rob Hayes (First Round Capital), Jim Tananbaum (Foresite Capital), Michael Rubin (Northpond Ventures), Nat Goldhaber
TenSixteen Bio
Series AJan 2022$40M
$40M
Co-investors: Vikram Bajaj (Foresite Capital)
Partner Google Ventures2009 - Present
Attending Partners HealthCare2009 - Present
New Business Development Google2008 - 2009
IMSA
Stanford University
Harvard Business School MBA
Harvard Medical School Doctor of Medicine (MD)